Canada markets open in 3 hours 53 minutes

Can-Fite BioPharma Ltd. (CANF)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
1.31000.0000 (0.00%)
At close: 04:00PM EST
1.2800 -0.03 (-2.29%)
After hours: 07:06PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.3100
Open1.2900
Bid1.2800 x 2200
Ask1.3000 x 1300
Day's Range1.2600 - 1.3100
52 Week Range0.9400 - 4.3900
Volume710,212
Avg. Volume3,891,498
Market Cap37.204M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-0.6900
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.08
  • Business Wire

    Prior to Phase III Psoriasis Data Release Can Fite Reports that Piclidenoson Destroys Pathological Skin Cells in vitro

    PETACH TIKVA, Israel, January 13, 2022--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced that pre-clinical studies with skin cells, modeling psoriasis in humans, show that Piclidenoson, the Company’s drug candidate for the treatment of psoriasis, destroys pathological skin cells. The Company’s scientists reported that in a cell culture

  • Business Wire

    Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference

    PETACH TIKVA, Israel, January 10, 2022--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and liver diseases, announced today that it will hold one-on-one virtual investor meetings during the J.P. Morgan Healthcare Conference.

  • Business Wire

    Can-Fite Issues Letter to Shareholders

    PETACH TIKVA, Israel, January 05, 2022--Can-Fite Issues Letter to Shareholders